Eric Rose, MD

Executive Vice President, MacAndrews & Forbes, Chief Executive Officer, Siga Technologies, Inc.

Dr. Eric Rose is an academic physician and entrepreneur with interests in drug discovery, biodefense, clinical evaluative research and health policy. Since 2007 he is the executive vice president for life sciences at MacAndrews & Forbes and CEO of Siga Technologies, Inc., a developer of an anti-viral drug directed at potential agents of bioterror. From 2007 through 2011, he served on the National Biodefense Scientific Board, which advises the HHS Secretary on biodefense, influenza, and emerging diseases. From 2008 through 2012, he chaired the Department of Health Evidence & Policy at the Mount Sinai School of Medicine. From 1994 through 2007, he served as surgeon-in-chief at New York-Presbyterian Hospital/Columbia and chairman of the department of surgery at the Columbia University College of Physicians and Surgeons, where he held a distinguished professorship. He has authored or co-authored more than 300 scientific publications and has received more than $25 million in NIH support for his research. Dr. Rose pioneered heart transplantation in children, performing the first successful pediatric heart transplant in 1984. Dr. Rose received both his undergraduate and medical degrees from Columbia University.